Dublin, Ireland, 11th April 2007 - AGI Therapeutics plc (“AGI” or the “Company”), a speciality pharmaceutical company focused on gastrointestinal drug products, today reports audited financial results for the twelve months ended 31 December 2006.
Dublin, Ireland, 11th April 2007 - AGI Therapeutics plc (“AGI” or the “Company”), a speciality pharmaceutical company focused on gastrointestinal drug products, today reports audited financial results for the twelve months ended 31 December 2006.
